Skip to main content
Terug
Watch Compare

Anika Therapeutics, Inc.

Datakwaliteit: 100%
ANIK
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 15,26
▲ € 0,05 (0,33%)
Marktkapitalisatie: 220,07 M
Prijs
€ 15,26
Marktkapitalisatie
220,07 M
Dagbereik
€ 15,01 — € 15,48
52-Weeksbereik
€ 7,87 — € 15,48
Volume
68.861
Openen € 15,09
50D / 200D Gem.
€ 12,39
23,16% above
50D / 200D Gem.
€ 10,32
47,88% above

Quick Summary

Belangrijkste Punten

Revenue declined -6,53% annually over 5 years
Generating 4,36 M in free cash flow
Capital efficient — spends only 6,05% of revenue on capex

Groei

Revenue Growth (5Y)
-6,53%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-5,91%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-7,39%
Boven sectorgemiddelde (-53,47%)
ROIC-5,11%
Net Margin-9,64%
Op. Margin-9,80%

Veiligheid

Debt / Equity
N/A
Current Ratio5,32
Interest CoverageN/A

Waardering

PE (TTM)
-20,23
Onder sectorgemiddelde (-1,47)
P/B Ratio1,50
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -20,2 -1,5
P/B 1,5 1,6
ROE % -7,4 -53,5
Net Margin % -9,6 -41,5
Rev Growth 5Y % -6,5 1,8
D/E — 0,3

ETFs Holding This Stock

SQLV logo SQLV Royce Quant Small-Cap Quality Value ETF
0,21% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,03% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,02% weight
GSCZX GSCZX
0,01% weight
GSCYX GSCYX
0,01% weight
EES logo EES WisdomTree U.S. SmallCap Fund
0,01% weight
VVICX VVICX
0,00% weight
IRSIX IRSIX
0,00% weight
IRCIX IRCIX
0,00% weight
IIRSX IIRSX
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -5,91% Revenue Growth (3Y) -17,72%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -6,53% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 112,82 M Net Income (TTM) -10,88 M
ROE -7,39% ROA -5,77%
Gross Margin 56,56% Operating Margin -9,80%
Net Margin -9,64% Free Cash Flow (TTM) 4,36 M
ROIC -5,11% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5,32
Interest Coverage N/A Asset Turnover 0,60
Working Capital 82,50 M Tangible Book Value 137,10 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -20,23 Forward P/E N/A
P/B Ratio 1,50 P/S Ratio 1,95
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1,98%
Market Cap 220,07 M Enterprise Value 162,08 M
Per Share
EPS (Diluted TTM) -0,76 Revenue / Share 7,82
FCF / Share 0,30 OCF / Share 0,78
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 6,05% FCF Conversion -40,09%
SBC-Adj. FCF -6,66 M Growth Momentum 0,62

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 112,82 M 119,91 M 166,66 M 156,24 M 147,79 M
Net Income -10,88 M -56,39 M -82,67 M -14,86 M 4,13 M
EPS (Diluted) -0,76 -3,83 -5,64 -1,02 0,28
Gross Profit 63,81 M 76,00 M 103,09 M 93,58 M 82,94 M
Operating Income -11,05 M -5,10 M -87,64 M -19,40 M 2,62 M
EBITDA — — — — —
R&D Expenses 25,77 M 25,54 M 32,69 M 28,18 M 27,33 M
SG&A Expenses 49,09 M 55,56 M 95,85 M 84,79 M 74,10 M
D&A 5,37 M 6,88 M 6,43 M 6,70 M 6,48 M
Interest Expense — — — — —
Income Tax 672.000,0 6,06 M -2,66 M -3,89 M -1,71 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 190,27 M 202,74 M 270,63 M 349,13 M 347,54 M
Total Liabilities — — — — —
Shareholders' Equity 143,47 M 153,99 M 212,27 M 285,56 M 287,09 M
Total Debt — — — — —
Cash & Equivalents 57,48 M 55,63 M 72,87 M 86,33 M 94,39 M
Current Assets 103,36 M 113,65 M 163,31 M 169,55 M 168,53 M
Current Liabilities 21,91 M 23,31 M 31,06 M 27,91 M 29,80 M